Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. - Wikidata - wikimedia - TriplyDB

Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.

Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.

http://www.wikidata.org/entity/Q37698331

about

Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)Development of improved pertussis vaccine.Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Harnessing the Therapeutic Potential of Th17 Cells.Advanced Role of Neutrophils in Common Respiratory Diseases CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells i Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections.Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1-/- mice.Noninvasive vaccination against infectious diseases.

P2860

Q33812212-600A9B36-C503-4142-9A4D-0836DD09C35E Q36113037-DB146737-DD2B-489C-AF23-F8B3CABFB5D2 Q36434174-0772AC8C-951D-4AB5-86ED-931A4C13D2A2 Q36978320-9C1E6B6F-AA33-4CFA-B158-196331309BAD Q37130834-9794CF31-6901-42AE-9523-B495F9AFF952 Q38535119-D9B67B0F-597F-4A4B-BAC4-C314095FB193 Q38739370-D13324AD-0017-494B-862F-451797B3534A Q38919640-D5AAC91A-F9EF-4B11-B5CA-C8F26849C0A7 Q40125532-1621C2DA-0517-40FC-A492-1642CF341885 Q40157987-A8B76A6F-A070-47E1-8445-8799104D696E Q52602778-7A6E5143-00D8-4DC3-ACD3-C924FBFBCA5A

P2860

Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.

http://www.wikidata.org/entity/Q37698331

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@en

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@nl

type

label

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@en

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@nl

prefLabel

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@en

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@nl

P1433

Q37698331-E0B0D3B5-38CE-4249-B6C7-7015E951428E

P1476

Q37698331-317C1749-CFDE-41FA-A54F-5A3CC4B9B249

P2093

Q37698331-02456482-0BAB-446C-9FAF-D3191E7C0E61

Q37698331-410D44AE-C766-469C-A826-94FD9C426311

Q37698331-73E10FB1-113B-41B3-B4FF-BBA645DDA72A

Q37698331-A1D3ED03-FD08-485B-AF49-1C8CA3FB73C9

Q37698331-D3624213-6CF3-4E24-B23A-9C857CBBE2F3

Q37698331-F24550F2-8A35-4682-9817-342641E8E522

P2860

Q37698331-07F4C199-9298-4608-9915-3C546DBA5A4B

Q37698331-0FB100D4-BA3A-4815-8384-8AB66AC6ED79

Q37698331-108A5DB3-F7EA-422C-933C-5DE3E1C9B42A

Q37698331-15D0EFC9-73D4-4B3D-9363-259756D8B430

Q37698331-183C1E21-0F01-4F40-85E4-EA889FF3490E

Q37698331-2582EE3F-1B83-47DF-9482-1259B107AEF4

Q37698331-29F61DB8-BA37-426F-9F53-3B98976A4D24

Q37698331-2A512756-A96F-4AD8-8B34-0EEE51B898B0

Q37698331-2CCB2B51-9228-42D6-9587-18BD6BEAD3B0

Q37698331-2DB702E8-AF60-415D-9955-0899D1A1B1B3

P304

Q37698331-B9D60B37-5941-41D4-A61A-FD8BDD08C159

P31

Q37698331-F8B94307-9ED6-46BE-ACA7-71FC78664A72

P356

Q37698331-08AB4CD3-AE78-4D88-8308-212D9FFE17D6

P407

Q37698331-F4C3F363-983D-4430-A261-1C7D92D04EA0

P433

Q37698331-D4E76145-D309-436A-9DF3-B6185259E493

P478

Q37698331-A227F2FA-A8AF-4C30-9020-A78055034049

P50

Q37698331-604B1FFF-E1D6-469B-A8E4-95A79399AD28

P577

Q37698331-2EB2B396-8DA4-47A2-BF4B-880EE97C7DFB

P698

Q37698331-D2F6B828-E9C6-4F2D-A8EB-F7CB51BE155A

P921

Q37698331-0955B401-0ADC-4D26-A802-0F59DCEB30E2

Q37698331-3B00FAC1-5EE0-4DAC-902E-985ED9B67051

P932

Q37698331-4BC61ACF-3509-4BC5-81B0-3AEFD16B2F65

P356

RCCM.201307-1227OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Attenuated Bordetella pertussi ...... an IL-17-dependent mechanism.

@en

P2093

Corinna Schnoeller

http://www.w3.org/2001/XMLSchema#string

Devika Sawant

http://www.w3.org/2001/XMLSchema#string

Dominique Raze

http://www.w3.org/2001/XMLSchema#string

Peter J Openshaw

http://www.w3.org/2001/XMLSchema#string

Wieslawa Olszewska

http://www.w3.org/2001/XMLSchema#string

Xavier Roux

http://www.w3.org/2001/XMLSchema#string

P2860

Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.

Influenza virus coinfection with Bordetella bronchiseptica enhances bacterial colonization and host responses exacerbating pulmonary lesions.

Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.

IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.

Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.

Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.

P304

194-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201307-1227OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24261996

http://www.w3.org/2001/XMLSchema#string

P921

Bordetella pertussis

attenuated vaccine

P932

3983892

http://www.w3.org/2001/XMLSchema#string